Search results
Earnings call: ADC Therapeutics sees revenue rise, advances ZYNLONTA trials
Investing.com· 7 days agoADC Therapeutics (NYSE: ADCT) has released its financial results for the first quarter of 2024,...
Grandfather saved by stem cells flies in to meet donor
The Telegraph via Yahoo News· 7 days ago“I saw it as an opportunity to help people, if I could do it then I thought ‘why not?’.”...
Karyopharm Announces Significant Refinancing Transactions and Amended Royalty Agreement Extending...
FOX 4 Kansas City· 4 days agoKaryopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, announced today that it has entered into a series of financing transactions ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 4 days agoPfizer also recently said its new drug, Adcetris, improved overall survival, progression-free...
Teenager’s cancer research, work with women in Nepal just the beginning for 18-year-old | Northwest...
Northwest Arkansas Democrat Gazette· 20 hours agoAarohi Sonputri of Little Rock hasn't quite graduated high school yet, but she's already racked up...
Cost and Kymriah: Financial assistance options, savings, more
Medical News Today· 2 days agoKymriah (tisagenlecleucel) is a brand-name intravenous (IV) infusion prescribed for certain blood...
Central Florida nurse cares for cancer patients after beating the illness in her own battle
WKMG ClickOrlando· 5 days agoAn AdventHealth registered nurse is able to go above and beyond when it comes to patient care...
Brokerages Set Incyte Co. (NASDAQ:INCY) PT at $74.93
ETF DAILY NEWS· 2 days agoIncyte Co. (NASDAQ:INCY – Get Free Report) has been given an average recommendation of “Hold” by the seventeen research firms that are covering the company, Marketbeat reports. Nine equities ...
Karyopharm Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
WKRN Nashville· 4 days ago– Announces Significant Refinancing Transactions and Amends Royalty Agreement with HealthCare Royalty Extending Vast Majority of Its Debt Maturities into 2028 and 2029, Well Beyond Expected ...
Metis Global Partners LLC Sells 549 Shares of Incyte Co. (NASDAQ:INCY)
ETF DAILY NEWS· 1 day agoMetis Global Partners LLC lessened its holdings in shares of Incyte Co. (NASDAQ:INCY – Free Report) by 6.6% in the 4th quarter, according to its most recent filing with the SEC. The fund owned ...